Safety and efficacy of ADG126 (an anti-CTLA-4 masking antibody) in combination with pembrolizumab: Updated results of phase 1b/2 study in advanced MSS CRC.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Daneng Li, Sun Young Kim, Manish R. Patel, Hee Kyung Kim, Sunil Sharma, Sang Joon Shin, Jeeyun Lee, Sae-Won Han, Luke Euichul Chung, Songmao Zheng, Yan Li, Ping Xiao, Kristine Xiaohong She, Dana HuLowe, Jiangchun Xu, Stanley R. Frankel, Michael Jon Chisamore, Peter Luo, Jiping Zha, Marwan Fakih
Institutions: City Of Hope National Medical Center, City of Hope, Asan Medical Center, University of Ulsan, Samsung Medical Center, Sungkyunkwan University, HonorHealth, Yonsei University Health System, Yonsei Cancer Hospital, Seoul National University, Seoul National University Hospital, Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410805586